Farnesyl transferase inhibitors cause enhanced mitotic sensitivity to taxol and epothilones
Mark M. Moasser(University of California, San Francisco), Neal Rosen(Memorial Sloan Kettering Cancer Center), Nancy E. Kohl(United States Military Academy), Laura Sepp‐Lorenzino(Intellia Therapeutics (United States)), Allen Oliff(GlaxoSmithKline (United Kingdom)), Aaron Balog(Bristol-Myers Squibb (United States)), Samuel J. Danishefsky(Kettering University), Dai‐Shi Su(Memorial Sloan Kettering Cancer Center)
Cited by 210
Related Papers
mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt
|Cancer Research|2006|2.5k
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
|Nature|2010|1.8k
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
|New England Journal of Medicine|2021|1.7k
RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
|Nature|2011|1.4k
BRAF mutation predicts sensitivity to MEK inhibition
|Nature|2005|1.3k